Organization and Principal Activities - Schedule of Subsidiaries (Details) |
12 Months Ended | |||||||
|---|---|---|---|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
|||||||
| Advanced Biomed Inc. [Member] | ||||||||
| Schedule of Subsidiaries [Line Items] | ||||||||
| Ownership interest | ||||||||
| Place of incorporation | Nevada, United States | |||||||
| Principal activities | Investment holding | |||||||
| Acellent Technologies (Hong Kong) Co. Limited [Member] | ||||||||
| Schedule of Subsidiaries [Line Items] | ||||||||
| Ownership interest | [1] | 100.00% | ||||||
| Place of incorporation | [1] | Hong Kong | ||||||
| Principal activities | [1] | Artificial intelligence and financial algorithmic software-related activities and agency services | ||||||
| Advanced Biomed Inc. (Taiwan) [Member] | ||||||||
| Schedule of Subsidiaries [Line Items] | ||||||||
| Ownership interest | [2] | 100.00% | ||||||
| Place of incorporation | [2] | Taiwan | ||||||
| Principal activities | [2] | Research and development of microfluidic technologies and cancer screening-related medical device applications | ||||||
| Advanced Biomed HK Limited [Member] | ||||||||
| Schedule of Subsidiaries [Line Items] | ||||||||
| Ownership interest | [3] | 100.00% | ||||||
| Place of incorporation | [3] | Hong Kong | ||||||
| Principal activities | [3] | Investment holding in the biotechnology sector | ||||||
| Shanghai Sglcell Biotech Co., Ltd. [Member] | ||||||||
| Schedule of Subsidiaries [Line Items] | ||||||||
| Ownership interest | [3] | 100.00% | ||||||
| Place of incorporation | [3] | Mainland China | ||||||
| Principal activities | [3] | Biotechnology-related market development and clinical activities | ||||||
| ||||||||